Literature DB >> 16751656

Rituximab induces regression of hepatitis C virus-related membranoproliferative glomerulonephritis in a renal allograft.

Oriol Bestard1, Josep M Cruzado, Guadalupe Ercilla, Montse Gomà, Joan Torras, Daniel Serón, Inés Rama, Meritxell Ibernon, Odette Viñas, Marta Carrera, Josep M Grinyó.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16751656     DOI: 10.1093/ndt/gfl266

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  5 in total

1.  Hepatitis C infection and chronic renal diseases.

Authors:  Aline Gonzalez Vigani
Journal:  Hepatol Int       Date:  2012-03-15       Impact factor: 6.047

Review 2.  Our experience with rituximab therapy for adult-onset primary glomerulonephritis and review of literature.

Authors:  Wai Yew Kong; Ramyasuda Swaminathan; Ashley Irish
Journal:  Int Urol Nephrol       Date:  2012-07-15       Impact factor: 2.370

Review 3.  Rituximab for Treatment of Membranoproliferative Glomerulonephritis and C3 Glomerulopathies.

Authors:  Michael Rudnicki
Journal:  Biomed Res Int       Date:  2017-05-09       Impact factor: 3.411

4.  Rituximab Treatment for PR3-ANCA-Positive Membranoproliferative Glomerulonephritis Associated with Adult-Onset Periodic Fever Syndrome.

Authors:  Yoshitomo Hamano; Hiromichi Yoshizawa; Taro Sugase; Takuya Miki; Naoko Ohtani; Shiho Hanawa; Eri Takeshima; Yoshiyuki Morishita; Osamu Saito; Fumi Takemoto; Shigeaki Muto; Wako Yumura; Eiji Kusano
Journal:  Case Rep Nephrol Urol       Date:  2012-07-11

5.  Life-Threatening Cryoglobulinemic Patients With Hepatitis C: Clinical Description and Outcome of 279 Patients.

Authors:  Soledad Retamozo; Cándido Díaz-Lagares; Xavier Bosch; Albert Bové; Pilar Brito-Zerón; Maria-Eugenia Gómez; Jordi Yagüe; Xavier Forns; Maria C Cid; Manuel Ramos-Casals
Journal:  Medicine (Baltimore)       Date:  2013-09       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.